Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Thanks Again, excellent article. Looking out over the remainder of the year and early next year, Marker's CEO sees three main milestones. "The next set of news releases will be the readout on the AML patients, update on how we're collecting data on the lymphoma group and how these patients are responding to the therapy, and lastly, update and progression on the off-the-shelf program"